Evidence map›Paper›PMID 34658087›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2021

Plasmonic Amyloid Tactoids.

Ye Yuan, Hamed Almohammadi, Julie Probst, Raffaele Mezzenga

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Plasmonic Amyloid Tactoids.Advanced materials (Deerfield Beach, Fla.) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ye YuanDepartment of Health Sciences and Technology, ETH Zürich, Zürich, 8092, Switzerland.
Hamed AlmohammadiDepartment of Health Sciences and Technology, ETH Zürich, Zürich, 8092, Switzerland.
Julie ProbstDepartment of Chemistry and Applied Biosciences, ETH Zürich, Zürich, 8093, Switzerland.
Raffaele MezzengaDepartment of Health Sciences and Technology, ETH Zürich, Zürich, 8092, Switzerland.ORCID https://orcid.org/0000-0002-5739-2610

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung CRSII5_189917Scientific Center for Optical and Electron Microscopy of ETH ZurichSwiss National Science Foundation CRSII5_189917
6 · The paper itself

Abstract

Despite their link to neurodegenerative diseases, amyloids of natural and synthetic sources can also serve as building blocks for functional materials, while possessing intrinsic photonic properties. Here, it is demonstrated that orientationally ordered amyloid fibrils exhibit polarization-dependent fluorescence, and can mechanically align rod-shaped plasmonic nanoparticles codispersed with them. The coupling between the photonic fibrils in liquid crystalline phases and the plasmonic effect of the nanoparticles leads to selective activation of plasmonic extinctions as well as enhanced fluorescence from the hybrid material. These findings are consistent with numerical simulations of the near-field plasmonic enhancement around the nanoparticles. The study provides an approach to synthesize the intrinsic photonic and mechanical properties of amyloid into functional hybrid materials, and may help improve the detection of amyloid deposits based on their enhanced intrinsic luminescence.

Indexed as

AmyloidGoldMetal NanoparticlesAmyloidGoldamyloid fibrilsfluorescencegold nanorodsliquid crystalsplasmonicsself-assembly

Identifiers

PMID34658087
PMCPMC11468577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.